targeting the mechanisms of treatment resistance in cancer with Nicholas  Goldner | 222

0 Lượt xem· 09/26/23
cancer – Learning with Lowell
cancer – Learning with Lowell
0 Người đăng ký
0
Trong

Nicholas Goldner, PhD, is the CEO and co-founder of resistanceBio, where he leads a mission to outsmart cancer by developing innovative therapies targeting treatment resistance mechanisms. He also serves as a venture partner at Pioneer... Source

Cho xem nhiều hơn

 0 Bình luận sort   Sắp xếp theo


Tiếp theo